|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 1796 for Tlr2

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.178s

Categories

Category: Publication
« show all
Type Details Score
Publication
23183169 | J:194208
First Author: Montalbano AP
Year: 2013
Journal: Endocrinology
Title: Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2 manifest delayed parturition and decreased expression of inflammatory and contractile genes.
Volume: 154
Issue: 1
Pages: 483-98
•
•
•
•
•
Publication
20478617 | J:160689
First Author: Leng CH
Year: 2010
Journal: Mol Immunol
Title: A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide.
Volume: 47
Issue: 11-12
Pages: 2015-21
•
•
•
•
•
Publication
18641352 | J:139229
First Author: Appledorn DM
Year: 2008
Journal: J Immunol
Title: Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo.
Volume: 181
Issue: 3
Pages: 2134-44
•
•
•
•
•
Publication
17056563 | J:140513
First Author: Monteiro AC
Year: 2006
Journal: J Immunol
Title: Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi.
Volume: 177
Issue: 9
Pages: 6325-35
•
•
•
•
•
Publication
16116224 | J:113220
First Author: Shi S
Year: 2005
Journal: J Immunol
Title: Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
Volume: 175
Issue: 5
Pages: 3318-28
•
•
•
•
•
Publication
30626205 | J:291829
First Author: Lee GL
Year: 2019
Journal: Arterioscler Thromb Vasc Biol
Title: TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
Volume: 39
Issue: 3
Pages: 432-445
•
•
•
•
•
Publication
26578650 | J:243093
First Author: Gomes MT
Year: 2016
Journal: J Leukoc Biol
Title: TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.
Volume: 99
Issue: 5
Pages: 771-80
•
•
•
•
•
Publication
12091878 | J:95726
First Author: Alexopoulou L
Year: 2002
Journal: Nat Med
Title: Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.
Volume: 8
Issue: 8
Pages: 878-84
•
•
•
•
•
Publication
28235196 | J:263531
First Author: Israel L
Year: 2017
Journal: Cell
Title: Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity.
Volume: 168
Issue: 5
Pages: 789-800.e10
•
•
•
•
•
Publication
31729371 | J:281617
First Author: Balounová J
Year: 2019
Journal: Nat Commun
Title: Toll-like receptor 2 expression on c-kit+ cells tracks the emergence of embryonic definitive hematopoietic progenitors.
Volume: 10
Issue: 1
Pages: 5176
•
•
•
•
•
Publication
16299338 | J:104301
First Author: Letiembre M
Year: 2005
Journal: Infect Immun
Title: Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes.
Volume: 73
Issue: 12
Pages: 8397-401
•
•
•
•
•
Publication
17854911 | J:128966
First Author: Lehnardt S
Year: 2007
Journal: J Neuroimmunol
Title: Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.
Volume: 190
Issue: 1-2
Pages: 28-33
•
•
•
•
•
Publication
16714598 | J:109232
First Author: Malik M
Year: 2006
Journal: Infect Immun
Title: Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis.
Volume: 74
Issue: 6
Pages: 3657-62
•
•
•
•
•
Publication
24815695 | J:211658
First Author: Ji L
Year: 2014
Journal: FEBS Lett
Title: Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways.
Volume: 588
Issue: 12
Pages: 2095-100
•
•
•
•
•
Publication
10358136 | J:55484
First Author: Heine H
Year: 1999
Journal: J Immunol
Title: Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin.
Volume: 162
Issue: 12
Pages: 6971-5
•
•
•
•
•
Publication
17889651 | J:158053
First Author: Jin MS
Year: 2007
Journal: Cell
Title: Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.
Volume: 130
Issue: 6
Pages: 1071-82
•
•
•
•
•
Publication
14978119 | J:88242
First Author: Knapp S
Year: 2004
Journal: J Immunol
Title: Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.
Volume: 172
Issue: 5
Pages: 3132-8
•
•
•
•
•
Publication
29367683 | J:260154
First Author: Kang SS
Year: 2018
Journal: Sci Rep
Title: Staphylococcal LTA antagonizes the B cell-mitogenic potential of LPS.
Volume: 8
Issue: 1
Pages: 1496
•
•
•
•
•
Publication
19358332 | J:148282
First Author: Chung SH
Year: 2009
Journal: Clin Immunol
Title: Staphylococcus aureus accelerates an experimental allergic conjunctivitis by Toll-like receptor 2-dependent manner.
Volume: 131
Issue: 1
Pages: 170-7
•
•
•
•
•
Publication
14738887 | J:105295
First Author: Villamón E
Year: 2004
Journal: Microbes Infect
Title: Toll-like receptor-2 is essential in murine defenses against Candida albicans infections.
Volume: 6
Issue: 1
Pages: 1-7
•
•
•
•
•
Publication
12874196 | J:120669
First Author: Báfica A
Year: 2003
Journal: J Immunol
Title: Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2.
Volume: 171
Issue: 3
Pages: 1123-7
•
•
•
•
•
Publication
15158187 | J:105414
First Author: Villamón E
Year: 2004
Journal: Microbes Infect
Title: Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis.
Volume: 6
Issue: 6
Pages: 542-8
•
•
•
•
•
Publication
16113258 | J:100417
First Author: Balloy V
Year: 2005
Journal: Infect Immun
Title: Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.
Volume: 73
Issue: 9
Pages: 5420-5
•
•
•
•
•
Publication
15569836 | J:112844
First Author: Knuefermann P
Year: 2004
Journal: Circulation
Title: Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart.
Volume: 110
Issue: 24
Pages: 3693-8
•
•
•
•
•
Publication
26489461 | J:277947
First Author: Kim C
Year: 2015
Journal: Cell Rep
Title: Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.
Volume: 13
Issue: 4
Pages: 771-782
•
•
•
•
•
Publication
11290799 | J:68705
First Author: Lehner MD
Year: 2001
Journal: J Immunol
Title: Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators.
Volume: 166
Issue: 8
Pages: 5161-7
•
•
•
•
•
Publication
21925592 | J:177515
First Author: Kadl A
Year: 2011
Journal: Free Radic Biol Med
Title: Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2.
Volume: 51
Issue: 10
Pages: 1903-9
•
•
•
•
•
Publication
23850672 | J:202108
First Author: Hu D
Year: 2013
Journal: Cell Immunol
Title: Stimulatory Toll-like receptor 2 suppresses restraint stress-induced immune suppression.
Volume: 283
Issue: 1-2
Pages: 18-24
•
•
•
•
•
Publication
29474374 | J:260344
First Author: Langer M
Year: 2018
Journal: PLoS One
Title: Neither Lys- and DAP-type peptidoglycans stimulate mouse or human innate immune cells via Toll-like receptor 2.
Volume: 13
Issue: 2
Pages: e0193207
•
•
•
•
•
Publication
38935789 | J:360393
First Author: Griesman T
Year: 2024
Journal: PLoS Pathog
Title: The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis.
Volume: 20
Issue: 6
Pages: e1012343
•
•
•
•
•
Publication
11276206 | J:130011
First Author: Werts C
Year: 2001
Journal: Nat Immunol
Title: Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.
Volume: 2
Issue: 4
Pages: 346-52
•
•
•
•
•
Publication
23402853 | J:201370
 
First Author: Winters L
Year: 2013
Journal: Neuroscience
Title: Expression analysis of genes involved in TLR2-related signaling pathway: Inflammation and apoptosis after ischemic brain injury.
Volume: 238
Pages: 87-96
•
•
•
•
•
Publication
36808423 | J:359953
First Author: Hu Z
Year: 2023
Journal: J Infect Dis
Title: The Impact of Aging and Toll-like Receptor 2 Deficiency on the Clinical Outcomes of Staphylococcus aureus Bacteremia.
Volume: 228
Issue: 3
Pages: 332-342
•
•
•
•
•
Publication
12198614 | J:125977
First Author: Echchannaoui H
Year: 2002
Journal: J Infect Dis
Title: Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation.
Volume: 186
Issue: 6
Pages: 798-806
•
•
•
•
•
Publication
32075760 | J:288071
First Author: Mulfaul K
Year: 2020
Journal: Cell Rep
Title: Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration.
Volume: 30
Issue: 7
Pages: 2209-2224.e5
•
•
•
•
•
Publication
20505832 | J:160817
First Author: Love W
Year: 2010
Journal: PLoS One
Title: Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma.
Volume: 5
Issue: 5
Pages: e10739
•
•
•
•
•
Publication
11896392 | J:75660
First Author: Toshchakov V
Year: 2002
Journal: Nat Immunol
Title: TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Volume: 3
Issue: 4
Pages: 392-8
•
•
•
•
•
Publication
15004175 | J:88606
First Author: Netea MG
Year: 2004
Journal: J Immunol
Title: Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.
Volume: 172
Issue: 6
Pages: 3712-8
•
•
•
•
•
Publication
16177057 | J:118997
First Author: Aravalli RN
Year: 2005
Journal: J Immunol
Title: Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus.
Volume: 175
Issue: 7
Pages: 4189-93
•
•
•
•
•
Publication
19801985 | J:157745
First Author: Barbalat R
Year: 2009
Journal: Nat Immunol
Title: Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands.
Volume: 10
Issue: 11
Pages: 1200-7
•
•
•
•
•
Publication
20923777 | J:167383
First Author: Hong J
Year: 2010
Journal: J Biol Chem
Title: Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death.
Volume: 285
Issue: 50
Pages: 39447-57
•
•
•
•
•
Publication
31170673 | J:295512
 
First Author: Murayama S
Year: 2019
Journal: J Neuroimmunol
Title: Activation of microglia and macrophages in the circumventricular organs of the mouse brain during TLR2-induced fever and sickness responses.
Volume: 334
Pages: 576973
•
•
•
•
•
Publication
23073832 | J:331086
First Author: Arroyo DS
Year: 2013
Journal: FASEB J
Title: Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy.
Volume: 27
Issue: 1
Pages: 299-312
•
•
•
•
•
Publication
17322885 | J:169893
First Author: Khor CC
Year: 2007
Journal: Nat Genet
Title: A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.
Volume: 39
Issue: 4
Pages: 523-8
•
•
•
•
•
Publication
11823477 | J:74463
First Author: Massari P
Year: 2002
Journal: J Immunol
Title: Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.
Volume: 168
Issue: 4
Pages: 1533-7
•
•
•
•
•
Publication
32698010 | J:313365
First Author: Imanishi T
Year: 2020
Journal: Cell Rep
Title: mTORC1 Signaling Controls TLR2-Mediated T-Cell Activation by Inducing TIRAP Expression.
Volume: 32
Issue: 3
Pages: 107911
•
•
•
•
•
Publication
20434372 | J:160611
First Author: Reynolds JM
Year: 2010
Journal: Immunity
Title: Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.
Volume: 32
Issue: 5
Pages: 692-702
•
•
•
•
•
Publication
19931471 | J:156189
First Author: Kang JY
Year: 2009
Journal: Immunity
Title: Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Volume: 31
Issue: 6
Pages: 873-84
•
•
•
•
•
Publication
27470911 | J:241162
 
First Author: Hanzelmann D
Year: 2016
Journal: Nat Commun
Title: Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants.
Volume: 7
Pages: 12304
•
•
•
•
•
Publication
19805031 | J:153704
First Author: Gallorini S
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides.
Volume: 106
Issue: 41
Pages: 17481-6
•
•
•
•
•
Publication
24589120 | J:213810
First Author: Choi JY
Year: 2014
Journal: Neurobiol Aging
Title: Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
Volume: 35
Issue: 7
Pages: 1643-53
•
•
•
•
•
Publication
28769782 | J:247895
 
First Author: DeKorver NW
Year: 2017
Journal: Front Aging Neurosci
Title: Toll-Like Receptor 2 Is a Regulator of Circadian Active and Inactive State Consolidation in C57BL/6 Mice.
Volume: 9
Pages: 219
•
•
•
•
•
Publication
31404078 | J:278088
First Author: Ihara F
Year: 2019
Journal: PLoS One
Title: Involvement of Toll-like receptor 2 in the cerebral immune response and behavioral changes caused by latent Toxoplasma infection in mice.
Volume: 14
Issue: 8
Pages: e0220560
•
•
•
•
•
Publication
21173309 | J:169246
First Author: McBride A
Year: 2011
Journal: Infect Immun
Title: Development of a secondary immune response to Mycobacterium tuberculosis is independent of Toll-like receptor 2.
Volume: 79
Issue: 3
Pages: 1118-23
•
•
•
•
•
Publication
23836823 | J:199819
First Author: Clark RB
Year: 2013
Journal: Infect Immun
Title: Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands.
Volume: 81
Issue: 9
Pages: 3479-89
•
•
•
•
•
Publication
21947775 | J:178477
First Author: Kobayashi F
Year: 2011
Journal: Infect Immun
Title: Production of autoantibodies by murine B-1a cells stimulated with Helicobacter pylori urease through toll-like receptor 2 signaling.
Volume: 79
Issue: 12
Pages: 4791-801
•
•
•
•
•
Publication
17170383 | J:136650
First Author: Dessing MC
Year: 2007
Journal: Am J Respir Cell Mol Biol
Title: Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.
Volume: 36
Issue: 5
Pages: 609-14
•
•
•
•
•
Publication
15593098 | J:156053
First Author: Kielian T
Year: 2005
Journal: Glia
Title: Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia.
Volume: 49
Issue: 4
Pages: 567-76
•
•
•
•
•
Publication
24002697 | J:317875
First Author: Kobayashi N
Year: 2014
Journal: Heart Vessels
Title: Porphyromonas gingivalis promotes neointimal formation after arterial injury through toll-like receptor 2 signaling.
Volume: 29
Issue: 4
Pages: 542-9
•
•
•
•
•
Publication
19930041 | J:162284
First Author: Silvestre R
Year: 2009
Journal: Immunology
Title: The contribution of Toll-like receptor 2 to the innate recognition of a Leishmania infantum silent information regulator 2 protein.
Volume: 128
Issue: 4
Pages: 484-99
•
•
•
•
•
Publication
19179417 | J:147168
First Author: Puliti M
Year: 2009
Journal: Infect Immun
Title: Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease.
Volume: 77
Issue: 4
Pages: 1524-31
•
•
•
•
•
Publication
21844233 | J:177780
First Author: Rahman MJ
Year: 2011
Journal: Infect Immun
Title: Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens.
Volume: 79
Issue: 11
Pages: 4649-56
•
•
•
•
•
Publication
11890657 | J:106263
 
First Author: Jones BW
Year: 2001
Journal: Ann Rheum Dis
Title: Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages.
Volume: 60 Suppl 3
Pages: iii6-12
•
•
•
•
•
Publication
19479087 | J:149313
First Author: Leemans JC
Year: 2009
Journal: PLoS One
Title: The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury.
Volume: 4
Issue: 5
Pages: e5704
•
•
•
•
•
Publication
28665005 | J:246487
First Author: Karim AF
Year: 2017
Journal: Eur J Immunol
Title: Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.
Volume: 47
Issue: 9
Pages: 1513-1524
•
•
•
•
•
Publication
17404273 | J:145288
First Author: Watanabe I
Year: 2007
Journal: J Immunol
Title: TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity.
Volume: 178
Issue: 8
Pages: 4917-25
•
•
•
•
•
Publication
21278324 | J:190218
First Author: Poole JA
Year: 2011
Journal: Am J Respir Cell Mol Biol
Title: Toll-like receptor 2 regulates organic dust-induced airway inflammation.
Volume: 45
Issue: 4
Pages: 711-9
•
•
•
•
•
Publication
21228220 | J:172784
First Author: Kellermayer R
Year: 2011
Journal: FASEB J
Title: Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice.
Volume: 25
Issue: 5
Pages: 1449-60
•
•
•
•
•
Publication
23223142 | J:196511
First Author: Kuo IH
Year: 2013
Journal: J Invest Dermatol
Title: Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
Volume: 133
Issue: 4
Pages: 988-98
•
•
•
•
•
Publication
18509040 | J:136387
First Author: Richard KL
Year: 2008
Journal: J Neurosci
Title: Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease.
Volume: 28
Issue: 22
Pages: 5784-93
•
•
•
•
•
Publication
30833653 | J:276649
First Author: Schuchardt M
Year: 2019
Journal: Sci Rep
Title: Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells.
Volume: 9
Issue: 1
Pages: 3421
•
•
•
•
•
Publication
31931293 | J:299931
 
First Author: Wan Z
Year: 2020
Journal: Int Immunopharmacol
Title: Role of Toll-like receptor 2 against Streptococcus uberis infection in primary mouse mammary epithelial cells.
Volume: 79
Pages: 106142
•
•
•
•
•
Publication
19541650 | J:150829
First Author: Zhou Q
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses.
Volume: 106
Issue: 26
Pages: 10740-5
•
•
•
•
•
Publication
28835616 | J:255786
First Author: Wang JW
Year: 2017
Journal: Sci Rep
Title: Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload.
Volume: 7
Issue: 1
Pages: 9193
•
•
•
•
•
Publication
23724118 | J:200789
First Author: Lachance C
Year: 2013
Journal: PLoS One
Title: Toll-like receptor 2-independent host innate immune response against an epidemic strain of Streptococcus suis that causes a toxic shock-like syndrome in humans.
Volume: 8
Issue: 5
Pages: e65031
•
•
•
•
•
Publication
20885960 | J:165105
First Author: Lowe EL
Year: 2010
Journal: PLoS One
Title: Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer.
Volume: 5
Issue: 9
Pages: e13027
•
•
•
•
•
Publication
17332486 | J:346495
First Author: Favre J
Year: 2007
Journal: Arterioscler Thromb Vasc Biol
Title: Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.
Volume: 27
Issue: 5
Pages: 1064-71
•
•
•
•
•
Publication
23314218 | J:325797
First Author: Xu Y
Year: 2013
Journal: Int J Mol Med
Title: Toll-like receptor 2 in promoting angiogenesis after acute ischemic injury.
Volume: 31
Issue: 3
Pages: 555-60
•
•
•
•
•
Publication
17517865 | J:123356
First Author: Cole LE
Year: 2007
Journal: Infect Immun
Title: Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
Volume: 75
Issue: 8
Pages: 4127-37
•
•
•
•
•
Publication
20407745 | J:162168
First Author: Ehses JA
Year: 2010
Journal: Diabetologia
Title: Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet.
Volume: 53
Issue: 8
Pages: 1795-806
•
•
•
•
•
Publication
11751980 | J:85323
First Author: Wooten RM
Year: 2002
Journal: J Immunol
Title: Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.
Volume: 168
Issue: 1
Pages: 348-55
•
•
•
•
•
Publication
21617141 | J:191857
First Author: Devaraj S
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.
Volume: 31
Issue: 8
Pages: 1796-804
•
•
•
•
•
Publication
36583707 | J:338748
First Author: Qian J
Year: 2023
Journal: FASEB J
Title: Toll-like receptor-2 in cardiomyocytes and macrophages mediates isoproterenol-induced cardiac inflammation and remodeling.
Volume: 37
Issue: 2
Pages: e22740
•
•
•
•
•
Publication
17621370 | J:123541
First Author: Layland LE
Year: 2007
Journal: Eur J Immunol
Title: Immunopathology in schistosomiasis is controlled by antigen-specific regulatory T cells primed in the presence of TLR2.
Volume: 37
Issue: 8
Pages: 2174-84
•
•
•
•
•
Publication
24614661 | J:210237
First Author: Moffitt K
Year: 2014
Journal: Infect Immun
Title: Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.
Volume: 82
Issue: 5
Pages: 2079-86
•
•
•
•
•
Publication
19106411 | J:163439
First Author: Blair P
Year: 2009
Journal: Circ Res
Title: Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase.
Volume: 104
Issue: 3
Pages: 346-54
•
•
•
•
•
Publication
18981147 | J:141076
First Author: Jana M
Year: 2008
Journal: J Immunol
Title: Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.
Volume: 181
Issue: 10
Pages: 7254-62
•
•
•
•
•
Publication
35756841 | J:333917
First Author: Di Lorenzo A
Year: 2022
Journal: Oncoimmunology
Title: Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
Volume: 11
Issue: 1
Pages: 2086752
•
•
•
•
•
Publication
16495560 | J:107379
First Author: Zhang C
Year: 2006
Journal: Infect Immun
Title: Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina.
Volume: 74
Issue: 3
Pages: 1857-64
•
•
•
•
•
Publication
22479357 | J:187126
First Author: Shakhov AN
Year: 2012
Journal: PLoS One
Title: Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).
Volume: 7
Issue: 3
Pages: e33044
•
•
•
•
•
Publication
24259498 | J:219534
First Author: Wang L
Year: 2014
Journal: Cardiovasc Res
Title: Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation.
Volume: 101
Issue: 3
Pages: 383-92
•
•
•
•
•
Publication
30826001 | J:293388
 
First Author: Li L
Year: 2019
Journal: Cell Immunol
Title: Toll-like receptor 2 deficiency promotes the generation of alloreactive Th17 cells after cardiac transplantation in mice.
Volume: 338
Pages: 9-20
•
•
•
•
•
Publication
23409051 | J:199343
First Author: Nicolò C
Year: 2013
Journal: PLoS One
Title: M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2.
Volume: 8
Issue: 2
Pages: e55819
•
•
•
•
•
Publication
18641340 | J:139261
First Author: Machata S
Year: 2008
Journal: J Immunol
Title: Lipoproteins of Listeria monocytogenes are critical for virulence and TLR2-mediated immune activation.
Volume: 181
Issue: 3
Pages: 2028-35
•
•
•
•
•
Publication
32404866 | J:292297
First Author: Mohammad M
Year: 2020
Journal: Sci Rep
Title: The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis.
Volume: 10
Issue: 1
Pages: 7936
•
•
•
•
•
Publication
18055842 | J:132201
First Author: Petersen B
Year: 2008
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Activation of Toll-like receptor 2 impairs hypoxic pulmonary vasoconstriction in mice.
Volume: 294
Issue: 2
Pages: L300-8
•
•
•
•
•
Publication
26739093 | J:229938
First Author: Xia X
Year: 2016
Journal: J Invest Dermatol
Title: Staphylococcal LTA-Induced miR-143 Inhibits Propionibacterium acnes-Mediated Inflammatory Response in Skin.
Volume: 136
Issue: 3
Pages: 621-30
•
•
•
•
•
Publication
11316801 | J:152519
First Author: Michelsen KS
Year: 2001
Journal: J Biol Chem
Title: The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2.
Volume: 276
Issue: 28
Pages: 25680-6
•
•
•
•
•
Publication
16861672 | J:112401
First Author: Herrmann I
Year: 2006
Journal: Infect Immun
Title: Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2.
Volume: 74
Issue: 8
Pages: 4841-8
•
•
•
•
•
Publication
29904087 | J:262632
First Author: Hooper MJ
Year: 2018
Journal: Sci Rep
Title: Damage-associated molecular pattern recognition is required for induction of retinal neuroprotective pathways in a sex-dependent manner.
Volume: 8
Issue: 1
Pages: 9115
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom